Prevention of iodinated contrast induced acute kidney injury (ICI-AKI) - what have we learnt so far?
Muhammad Asim
Department of Medicine, Nephrology Section, Hamad General Hospital, Doha, Qatar
Correspondence Address:
Muhammad Asim Department of Medicine, Nephrology Section, Hamad General Hospital P.O. Box 3050, Doha Qatar
Check
PMID: 19736469
The use of imaging modalities and endovascular procedures has escalated phenolmenally in the last two decades. In view of increasing number of elderly patients, rising incidence of chronic kidney disease and diabetes along with the complication of nephrogenic systemic fibrosis with gadolinium, a large patient population will be at risk of developing iodinated contrast induced acute kidney injury (ICI-AKI) which is associated with significant morbidity and mortality and increased health care costs. Hence a search for more effective ways to prevent ICIAKI continues to be a focus within the medical community.
